despit
intens
effort
develop
novel
better
tool
identifi
known
virus
discov
new
virus
establish
etiolog
role
virus
human
diseas
challeng
larg
part
may
attribut
high
variabl
viral
speci
difficulti
develop
broadspectrum
yet
specif
diagnost
assay
overcom
problem
novel
method
detect
virus
describ
current
manuscript
techniqu
reli
addit
synthet
oligonucleotid
termini
rna
fragment
sequencedepend
manner
firstand
secondstrand
dna
synthesi
oligonucleotid
use
subsequ
amplif
viral
nucleic
acid
interest
recognit
target
sequenc
oligonucleotid
mediat
short
nt
conserv
region
facilit
develop
broadspectrum
assay
method
test
coronavirus
although
may
also
adopt
rna
virus
viral
infect
impos
great
diseas
burden
human
popul
well
known
viral
diseas
viral
infect
thought
play
role
pathogenesi
mani
diseas
howev
detect
identif
virus
difficult
establish
etiolog
role
virus
diseas
challeng
particularli
true
chronic
condit
eg
kawasaki
diseas
viru
load
low
presenc
viru
time
sampl
uncertain
baker
et
al
christen
et
al
simo
et
al
surprisingli
may
also
true
acut
infect
eg
respiratori
tract
infect
etiolog
agent
identifi
larg
proport
case
ali
et
al
bezerra
et
al
hayden
et
al
mahoni
et
al
regamey
et
al
sanghavi
et
al
thomazelli
et
al
although
failur
identifi
infect
viru
may
due
presenc
novel
pathogen
shown
previous
also
due
imperfect
diagnost
system
pyrc
et
al
coronavirus
larg
envelop
singlestrand
rna
virus
genom
nucleic
acid
kb
shield
nucleocapsid
protein
interact
membran
envelop
spike
protein
form
viabl
envelop
viral
particl
field
et
al
present
three
major
group
coronavirus
recogn
alpha
betaand
gammacoronavirus
cluster
speci
share
similar
genom
structur
gener
characterist
intern
committe
taxonomi
virus
king
gener
alphaand
betacoronavirus
consid
mammalian
pathogen
gammacoronavirus
mostli
infect
bird
field
et
al
two
human
coronavirus
recogn
research
group
pathogen
rel
limit
bradburn
et
al
kapikian
et
al
mcintosh
et
al
mcintosh
et
al
reed
tyrrel
byno
emerg
sever
acut
respiratori
syndrom
coronaviru
sarscov
winter
season
highlight
import
coronavirida
famili
human
health
drosten
et
al
ksiazek
et
al
peiri
et
al
realiz
threat
animalhuman
transmiss
coronavirus
acceler
research
virus
result
identif
two
novel
human
coronavirus
appear
resid
human
popul
mani
year
undetect
diagnost
method
use
time
van
der
hoek
et
al
woo
et
al
sever
techniqu
describ
detect
coronavirus
gener
oldest
electron
microscopi
allow
visual
viral
particl
infecti
materi
hamr
procknow
mcintosh
et
al
sinc
identif
first
coronavirus
electron
microscopi
sever
method
develop
rang
cell
cultur
immun
detect
molecular
detect
pyrc
et
al
schildgen
et
al
recent
sophist
method
develop
includ
sequenceindepend
techniqu
allow
amplif
nucleic
acid
regardless
sequenc
approach
result
amplif
target
origin
host
genet
materi
well
target
viral
origin
comparison
noninfect
control
sampl
virusinfect
sampl
allow
research
select
nucleic
acid
sequenc
motif
present
exclus
latter
set
sampl
alland
et
al
alland
et
al
anway
et
al
lu
et
al
van
der
hoek
et
al
interest
commonli
use
diagnost
approach
employ
degener
univers
primer
abl
detect
coronavirus
share
sequenc
homolog
select
conserv
site
theoret
also
includ
member
famili
unrecogn
previous
adachi
et
al
drosten
et
al
escutenair
et
al
ksiazek
et
al
moe
et
al
stephensen
et
al
approach
promis
although
high
variabl
viral
sequenc
coupl
limit
level
degener
primer
may
lead
falseneg
result
viral
speci
ident
refer
strain
overcom
problem
codehop
techniqu
develop
allow
design
highli
degener
dna
primer
base
conserv
protein
sequenc
rose
et
al
zlateva
et
al
current
manuscript
describ
develop
novel
method
detect
rna
virus
combin
extent
select
univers
primer
approach
broad
specif
sequenceindepend
method
method
reli
design
synthet
oligonucleotid
compris
short
nt
element
recogn
conserv
region
viral
nucleic
acid
longer
nt
anchor
element
oligonucleotid
ad
termini
rna
fragment
firstand
secondstrand
dna
synthesi
anchor
region
subsequ
use
amplif
analysi
viral
nucleic
acid
use
short
nt
conserv
region
recogn
target
sequenc
facilit
design
develop
broadspectrum
assay
therefor
increas
applic
method
although
sensit
method
limit
thu
suitabl
detect
cultiv
pathogen
potenti
recogn
unknown
member
coronavirida
famili
mean
valuabl
addit
rang
viru
detect
identif
tool
alreadi
exist
viru
stock
gener
infect
hela
cell
atcc
adenoviru
rd
cell
atcc
enteroviru
cell
atcc
parainfluenza
type
human
metapneumoviru
hmpv
human
respiratori
syncyti
viru
hrsv
mdck
cell
atcc
influenza
b
case
cell
lyse
two
freezethaw
cycl
appear
cytopath
effect
viruscontain
fluid
aliquot
store
c
control
cell
lysat
mockinfect
cell
prepar
manner
viru
stock
parainfluenza
virus
influenza
b
viru
isol
clinic
sampl
process
laboratori
stock
sampl
contain
influenza
viru
enteroviru
human
echoviru
hrsv
human
parainfluenza
viru
human
adenoviru
provid
kindli
marcel
muller
univers
bonn
medic
center
germani
kind
gift
lia
van
der
hoek
academ
medic
center
univers
amsterdam
netherland
hmpv
human
coronaviru
provid
kindli
oliv
schildgen
univers
hospit
wittenherdeck
cologn
germani
astrid
vabret
univers
hospit
caen
franc
respect
identifi
conserv
site
coronaviru
sequenc
three
approach
use
dedic
hexaprim
softwar
describ
section
hexaprim
softwar
bioedit
ver
http
wwwmbioncsuedubioeditbioedithtml
automat
conserv
site
finder
visual
inspect
applic
approach
allow
appropri
screen
coronaviru
sequenc
data
genbank
number
sequenc
includ
analysi
follow
rna
clinic
specimen
viral
cultur
supernat
extract
use
total
rna
mini
kit
biotechnolog
gdynia
poland
accord
manufactur
protocol
dna
isol
use
viral
dnarna
kit
biotechnolog
gdynia
poland
accord
manufactur
instruct
follow
extract
sampl
incub
min
c
dnase
dnase
turbo
thermo
scientif
vilniu
lithuania
rna
reisol
follow
isol
total
rna
precipit
presenc
g
glycogen
life
technolog
warsaw
poland
three
volum
isopropanol
h
c
sampl
centrifug
subsequ
g
min
result
pellet
wash
ethanol
dri
min
room
temperatur
resuspend
l
nucleasefre
water
sigmaaldrich
poznan
poland
purifi
rna
store
c
isol
nucleic
acid
see
section
revers
transcrib
high
capac
cdna
revers
transcript
kit
life
technolog
warsaw
poland
accord
manufactur
instruct
viru
yield
determin
use
realtim
pcr
standard
curv
previous
describ
golda
et
al
pyrc
et
al
briefli
five
microlit
cdna
amplifi
l
reaction
mixtur
contain
taqman
univers
pcr
master
mix
amperas
ung
life
technolog
warsaw
poland
specif
probe
label
fam
tamra
nm
primer
nm
primer
probe
list
tabl
rox
use
refer
dye
reaction
monitor
fast
realtim
pcr
machin
life
technolog
warsaw
poland
follow
set
min
c
min
c
cycl
c
min
c
total
rna
isol
purifi
describ
section
use
synthesi
first
second
cdna
strand
five
microlit
total
rna
mix
pm
l
revers
transcript
rt
primer
list
rt
primer
use
current
studi
given
tabl
incub
c
min
cool
ice
min
mix
rt
mix
u
multiscrib
revers
transcriptas
life
technolog
warsaw
poland
l
dna
polymeras
buffer
thermo
scientif
vilniu
lithuania
l
mm
dntp
l
dmso
total
volum
l
reaction
carri
min
c
follow
incub
sampl
heatinactiv
c
min
result
singlestrand
cdna
use
secondstrand
synthesi
purif
step
inbetween
briefli
sampl
l
denatur
min
c
cool
ice
subsequ
l
secondstrand
mix
ad
u
rnase
h
l
dna
polymeras
buffer
u
dna
polymeras
thermo
scientif
vilniu
lithuania
l
dmso
pm
secondstrand
ss
primer
list
ss
primer
use
current
studi
given
tabl
sampl
incub
min
c
subsequ
doublestrand
cdna
purifi
mean
phenol
chloroform
isoamyl
alcohol
ph
isol
dna
result
sampl
precipit
l
isopropanol
h
c
centrifug
g
min
wash
ethanol
dri
room
temperatur
min
resuspend
l
nucleasefre
water
sigmaaldrich
poznan
poland
result
doublestrand
dna
use
directli
amplif
accord
protocol
given
amplif
carri
total
volum
l
dreamtaq
pcr
master
mix
thermo
scientif
vilniu
lithuania
presenc
pm
forward
revers
primer
rt
ss
primer
templat
dna
l
first
pcr
cycl
condit
includ
initi
denatur
min
c
follow
cycl
c
c
c
min
c
final
elong
second
nest
pcr
reaction
prepar
similar
manner
l
first
pcr
mixtur
templat
pm
primer
list
primer
use
current
studi
given
tabl
cycl
condit
includ
initi
denatur
min
c
follow
cycl
c
c
decreas
c
per
cycl
c
cycl
c
c
c
min
c
final
elong
follow
reaction
l
sampl
load
onto
agaros
gel
visual
ethidium
bromid
determin
sensit
assay
serial
dilut
viru
stock
describ
section
use
concentr
rang
copi
per
reaction
determin
use
realtim
pcr
rt
ss
synthesi
pcr
nest
pcr
conduct
describ
section
effici
differ
ss
synthesi
enzym
polymeras
thermo
scientif
vilniu
lithuania
dna
polymeras
thermo
scientif
vilniu
lithuania
sequenas
affymetrix
unit
kingdom
evalu
mean
densitometri
follow
band
separ
agaros
gel
test
whether
possibl
detect
coronavir
rna
cell
cultur
also
clinic
sampl
l
aliquot
clinic
specimen
includ
sputum
bronchoalveolar
lavag
fluid
nose
wash
test
neg
known
pathogen
pyrc
et
al
spike
l
viru
stock
final
tcid
subsequ
hexaprim
assay
carri
result
product
analyz
agaros
gel
determin
whether
coronaviru
primer
chosen
current
studi
specif
amplifi
coronaviru
nucleic
acid
hexaprim
assay
primer
also
conduct
sever
human
virus
includ
influenza
b
virus
parainfluenza
virus
hrsv
human
adenoviru
human
rhinoviru
hmpv
human
echoviru
briefli
viral
nucleic
acid
isol
concentr
describ
section
sampl
subject
hexaprim
assay
use
primer
set
tabl
describ
section
logic
hexaprim
primer
design
similar
univers
primer
pcr
design
therefor
presenc
conserv
site
nucleic
acid
viral
group
interest
prerequisit
hand
also
share
characterist
sequenceindepend
method
anchor
oligonucleotid
ad
flank
region
interest
serv
templat
tabl
evalu
primer
set
ss
secondstrand
synthesi
rt
revers
transcript
primer
second
amplif
step
see
fig
subsequ
amplif
first
isol
rna
subject
rt
primer
design
use
hexaprim
softwar
primer
rt
primer
use
revers
transcript
first
pcr
amplif
consist
short
nt
element
homolog
conserv
region
present
target
genom
longer
nt
artifici
anchor
sequenc
use
templat
pcr
amplif
fig
follow
rt
rnadna
duplex
disrupt
rnase
h
mixtur
dna
polymeras
ss
primer
use
secondstrand
synthesi
first
pcr
ad
sampl
primer
ss
synthesi
construct
manner
rt
primer
therefor
ss
synthesi
result
addit
anoth
anchor
nt
end
amplifi
fragment
fig
result
doublestrand
dna
flank
synthet
oligonucleotid
anchor
termini
use
first
pcr
amplif
rt
ss
primer
product
amplif
use
subsequ
nest
amplif
primer
amplifi
target
within
templat
dna
amplif
result
gener
short
amplicon
visual
standard
agaros
gel
sequenc
gener
overview
hexaprim
assay
present
fig
design
appropri
primer
detect
coronavirus
set
coronavir
sequenc
obtain
genbank
databas
access
number
provid
section
sequenc
align
inspect
presenc
short
conserv
region
inspect
perform
three
independ
approach
hexaprim
softwar
javabas
softwar
identif
conserv
sequenc
develop
current
studi
softwar
avail
publicli
http
wwwvirogeneticsinfo
detail
see
section
hexaprim
softwar
bioedit
conserv
sequenc
identifi
base
automat
conserv
site
finder
featur
softwar
sequenc
inspect
eye
conserv
sequenc
mark
analysi
led
identif
sever
conserv
region
nt
allow
design
multipl
primer
set
list
tabl
fragment
select
base
sequenc
ident
alon
without
preselect
base
locat
predict
rna
structur
hexaprim
softwar
identif
conserv
site
multipl
viral
genom
prepar
java
environ
hexaprim
analysi
collect
sequenc
interest
fasta
format
prepar
analysi
sequenc
divid
overlap
word
desir
length
subsequ
sequenc
word
convert
bit
array
array
correspond
sequenc
multipli
logic
result
array
contain
word
present
test
sequenc
approach
appear
effect
simpl
comparison
sequenc
provid
complet
inform
presenc
certain
nucleotid
stretch
whole
genom
sequenc
may
import
silico
screen
potenti
primer
pair
result
list
word
contain
inform
posit
word
fig
hexaprim
assay
briefli
revers
transcript
rt
secondstrand
ss
synthesi
reaction
conduct
total
rna
black
presenc
primer
compris
short
nt
element
recogn
conserv
region
viral
nucleic
acid
dark
green
dark
blue
rt
ss
primer
respect
longer
nt
anchor
serv
templat
subsequ
pcr
amplif
light
green
light
blue
rt
ss
primer
respect
product
pcr
amplif
coronavir
rna
may
analyz
gel
electrophoresi
sequenc
genom
therefor
recov
subsequ
sequenc
data
distanc
word
pair
determin
result
present
list
word
distanc
posit
origin
sequenc
genom
overview
method
present
fig
valid
design
primer
set
test
sampl
contain
rna
step
procedur
evalu
optim
care
determin
optim
reaction
condit
briefli
differ
enzym
buffer
concentr
salt
primer
thermal
profil
amplif
test
result
describ
manuscript
due
space
constraint
final
optim
condit
present
rna
isol
viru
stock
concentr
precipit
presenc
glycogen
concentr
rna
sampl
result
proport
increas
viru
yield
determin
realtim
pcr
data
shown
subsequ
analysi
show
step
also
enhanc
sensit
hexaprim
assay
data
shown
isol
concentr
rna
process
accord
hexaprim
method
describ
section
briefli
rna
revers
transcrib
use
multiscrib
revers
transcriptas
rt
primer
list
tabl
secondstrand
synthesi
conduct
use
dna
polymeras
ss
primer
list
tabl
first
second
pcr
amplif
conduct
rtss
primer
primer
respect
gel
electrophoresi
result
product
yield
sever
band
although
amplif
primer
set
yield
distinct
band
sampl
contain
viral
rna
fig
dna
fragment
appropri
size
excis
gel
isol
clone
plasmid
clone
sequenc
ident
confirm
base
assay
perform
densitometri
sequenc
result
primer
set
use
subsequ
analys
alphaand
betacoronavirus
fig
determin
sensit
hexaprim
assay
concentr
viral
rna
cultur
sampl
determin
use
realtim
pcr
follow
rna
concentr
set
copi
ml
serial
dilut
copi
ml
prepar
sampl
subject
hexaprim
assay
result
present
fig
show
assay
sensit
copi
ml
test
whether
perform
vaguest
step
reaction
ie
ss
synthesi
optim
effort
made
evalu
enzym
abl
carri
ss
synthesi
clearli
visibl
fig
dna
polymeras
polymeras
show
similar
effici
ss
synthesi
sequenas
result
discret
band
determin
whether
hexaprim
assay
specif
toward
coronavirus
primer
set
coronavirus
test
crossreact
viral
nucleic
acid
respiratori
pathogen
briefli
rna
dna
hmpv
adenoviru
rhinoviru
enteroviru
influenza
b
virus
parainfluenza
virus
hrsv
isol
cell
cultur
subject
hexaprim
assay
without
dilut
even
though
background
amplif
observ
sampl
crossreact
ie
product
similar
size
quantiti
detect
assay
show
hexaprim
assay
highli
specif
fig
amplif
observ
neg
control
sampl
mockinfect
cell
cultur
water
tabl
test
amplif
primer
set
yield
distinct
band
sequenc
product
analysi
fragment
size
reveal
primer
set
allow
effici
amplif
desir
product
size
marker
mockinfect
cell
cultur
supernat
b
detect
hexaprim
assay
use
primer
set
experiment
procedur
conduct
describ
section
size
marker
w
water
mockinfect
virusinfect
cell
cultur
supernat
c
sensit
hexaprim
assay
concentr
sampl
contain
viral
rna
copi
ml
subject
serial
dilut
cell
cultur
supernat
hexaprim
assay
conduct
rna
concentr
three
differ
enzym
ss
dna
synthesi
trial
b
c
denot
dna
polymeras
polymeras
sequenas
respect
hexaprim
assay
design
detect
viral
rna
complex
clinic
specimen
therefor
assay
perform
evalu
use
differ
sampl
type
includ
nose
wash
bronchoalveolar
lavag
fluid
sputum
spike
viru
briefli
l
cultur
supernat
cell
infect
inocul
l
clinic
sampl
type
previous
test
neg
coronavirus
reaction
perform
accord
protocol
describ
result
fig
specif
hexaprim
assay
hexaprim
assay
conduct
sampl
contain
differ
human
respiratori
virus
includ
human
metapneumoviru
hmpv
adenoviru
adv
rhinoviru
rv
enteroviru
ev
influenza
b
virus
iav
ibv
respect
parainfluenza
virus
respect
respiratori
syncyti
viru
rsv
size
marker
product
analyz
standard
gel
electrophoresi
inhibit
reaction
observ
clinic
sampl
test
fig
numer
method
develop
detect
viral
pathogen
univers
primer
approach
limit
undoubtedli
sensit
method
semigener
detect
moe
et
al
pyrc
et
al
hand
appropri
identifi
virus
close
relat
known
virus
detect
novel
virus
detect
use
univers
primer
sever
sequenceindepend
techniqu
develop
includ
randomprim
pcr
represent
differ
analysi
rda
viru
discoveri
base
cdna
amplifi
fragment
length
polymorph
vidisca
adachi
et
al
alland
et
al
alland
et
al
anway
et
al
drosten
et
al
escutenair
et
al
ksiazek
et
al
lu
et
al
moe
et
al
stephensen
et
al
van
der
hoek
et
al
method
name
sequenceindepend
amplif
driven
specif
primer
instead
random
semirandom
amplif
carri
exampl
randomprim
pcr
method
util
primer
contain
random
nucleotid
termini
abl
attach
amplifi
target
includ
viral
genet
materi
indiscrimin
fouchier
et
al
specif
approach
employ
rda
primer
select
arbitrarili
use
follow
pcr
reaction
infect
sampl
compar
noninfect
sampl
liang
parde
lu
et
al
differ
approach
employ
vidisca
sispa
method
whole
amplif
process
base
presenc
common
restrict
site
rnadna
molecul
follow
enzymat
restrict
restrict
site
serv
site
ligat
synthet
dna
fragment
turn
constitut
primer
attach
site
way
everi
fragment
flank
certain
restrict
site
amplifi
comparison
characterist
amplif
pattern
infect
control
sampl
may
serv
identifi
nucleic
acid
viral
origin
unfortun
approach
extrem
labori
highthroughput
analysi
possibl
alland
et
al
rey
kim
van
der
hoek
et
al
current
manuscript
novel
assay
detect
coronavirus
present
hexaprim
assay
although
sensit
assay
primer
set
test
current
work
indisput
lower
describ
univers
primer
similar
describ
sequenceindepend
method
shorter
conserv
nucleotid
stretch
requir
success
prime
major
advantag
hexaprim
assay
provid
broader
specif
compar
standard
univers
primer
approach
also
worth
note
method
sequenceindepend
detect
viral
pathogen
eg
vidisca
rda
requir
highlytrain
personnel
appropri
infrastructur
hexaprim
assay
rel
simpl
addit
step
compar
typic
nest
pcr
ligat
anchor
end
rna
fragment
singletub
reaction
increas
sensit
method
addit
step
ad
protocol
includ
precipit
rna
presenc
glycogen
concentr
method
confirm
effect
quantit
pcr
data
shown
addit
step
may
therefor
also
benefici
viru
detect
method
vidisca
sispa
alland
et
al
van
der
hoek
et
al
analys
perform
current
studi
show
clearli
hexaprim
assay
highli
specif
coronavir
speci
may
therefor
use
routin
screen
clinic
sampl
due
limit
sensit
method
vitro
cultur
pathogen
may
prerequisit
success
amplif
end
fullydifferenti
airway
epithelium
cultur
may
use
preamplif
tool
increas
titer
airway
virus
pyrc
et
al
obvious
due
technic
limit
method
may
use
mostli
research
facil
focus
discoveri
new
pathogen
rather
clinic
virolog
laboratori
set
method
test
detect
virus
belong
singl
viral
famili
thu
far
although
may
also
adopt
rna
virus
